Aaron Topol is a Scientist at insitro since May 2021, with a previous role as a Research Associate at Verily Life Sciences from December 2016 to May 2021. Prior experience includes a Graduate Student position at the Icahn School of Medicine at Mount Sinai from October 2012 to December 2016, where contributions involved high-throughput transcriptional manipulation related to schizophrenia using CRISPR/Cas9. Notable achievements include independently executing a project on editing schizophrenia-associated SNPs, leading to multiple co-first and first author publications. Earlier, Aaron worked as an intern at the San Diego Center for Algae Biotechnology and the Genomics Institute of the Novartis Research Foundation, as well as held data assistant roles at UCSD Moore's Cancer Center and Stanford University School of Medicine. Educational qualifications include a Master's Degree in Biomedical Sciences from the Icahn School of Medicine at Mount Sinai and a Bachelor of Science in Molecular Biology from UC San Diego.
This person is not in any teams
This person is not in any offices